Register Login

C4 THERAPEUTICS, INC. (CCCC)

(90% Positive) C4 THERAPEUTICS, INC. (CCCC) Announces Enrollment Update for results Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Aug. 11, 2026, 11:17 a.m.

    📋 C4 THERAPEUTICS, INC. (CCCC) - Clinical Trial Update

    Filing Date: 2026-08-11

    Accepted: 2026-08-11 07:14:05

    Event Type: Clinical Trial Update

    Event Details:

    C4 THERAPEUTICS, INC. (CCCC) Announces Clinical Trial Update C4 THERAPEUTICS, INC. (CCCC) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: results, Initiate
    • Diseases/Conditions: cemsidomide
    • Clinical Stage: Phase 2, Phase 1
    • Collaboration: European Hematology Association
      • Class Profile in Multiple MyelomaPhase 1b Trial of Cemsidomide in Combination With Approved Standard of Care Multiple Myeloma Therapies On Track to Initiate in 1H 2027WATERTOWN, Mass., August 11, 2026 (GLOBE NEWSWIRE)
      • - C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical
      • stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today reported financial results for the second quarter ended June 30, 2026, as well as recent
        • expected in mid-2027
        • expected in the second half of 2027

    🔬 Clinical Development Pipeline (C4 THERAPEUTICS, INC.):

    Product Type Development Stage Therapeutic Area Source
    Cemsidomide Other Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Dexamethasone Other Phase PHASE2 Multiple Myeloma ClinicalTrials.gov
    Elranatamab Other Phase PHASE1 Multiple Myeloma (MM) ClinicalTrials.gov
    CFT8634 Other Phase PHASE1 Synovial Sarcoma ClinicalTrials.gov
    Cetuximab Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Trametinib Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    CFT1946 Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Dexamethasone Oral Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: C4 THERAPEUTICS, INC.
    • Ticker Symbol: CCCC

Search

News categories